Optimizing Postoperative Anticoagulation Regimen to Improve Lower Extremity Free Flap Outcomes.

IF 2.2 3区 医学 Q2 SURGERY
Kylie R Swiekatowski, Delani E Woods, Ellen B Wang, Edwin Acevedo, David C Hopkins, Mohin A Bhadkamkar, Yuewei Wu-Fienberg
{"title":"Optimizing Postoperative Anticoagulation Regimen to Improve Lower Extremity Free Flap Outcomes.","authors":"Kylie R Swiekatowski, Delani E Woods, Ellen B Wang, Edwin Acevedo, David C Hopkins, Mohin A Bhadkamkar, Yuewei Wu-Fienberg","doi":"10.1055/a-2555-2252","DOIUrl":null,"url":null,"abstract":"<p><p>Free flap reconstruction for lower extremity (LE) trauma has a higher failure rate than free flaps in other anatomic regions. Postoperative anticoagulation and antiplatelet therapy may influence LE free flap outcomes, but an optimal regimen has not been established. This study aims to evaluate complication rates associated with different anticoagulation and antiplatelet protocols in LE free flap reconstruction.Adult patients (≥18 years of age) with LE trauma requiring free flap reconstruction at our level 1 trauma center from 2016 to 2021 were included for retrospective chart review. Complications requiring reoperation were grouped into a composite variable named major complications (i.e., hematoma, flap thrombosis, flap necrosis >10%, infection requiring reoperation). Nonrandomized patients were categorized into three groups based on postoperative anticoagulation or antiplatelet regimen (aspirin only, heparin only, and aspirin + heparin), with heparin being a subtherapeutic fixed-dose heparin infusion at 500 to 800 units/hour. Complication rates were compared across groups, and both univariate and multivariate analyses were conducted to identify associations with major complications. <i>p</i>-Values were set at <i>p</i> < 0.05.Of 191 patients, 37 (19.4%) received aspirin only, 76 (39.8%) received heparin only, and 78 (40.8%) received aspirin + heparin. Demographics were similar between the groups. On univariate analysis, the heparin group had a significantly lower rate of major complications (5.26%) compared with aspirin only (18.92%) and aspirin + heparin (20.51%; <i>p</i> = 0.016); however, on multivariate analysis, when accounting for additional perioperative factors, no association between anticoagulation group and major complications was found.Our study found that neither aspirin alone, heparin alone, or aspirin + heparin demonstrated a more favorable association with LE free flap outcomes. To reduce bias from the study's retrospective design and the surgeon's discretion in choosing anticoagulation protocols, future research should randomize patients to standardized postoperative regimens to assess differences in complications.</p>","PeriodicalId":16949,"journal":{"name":"Journal of reconstructive microsurgery","volume":" ","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of reconstructive microsurgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2555-2252","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Free flap reconstruction for lower extremity (LE) trauma has a higher failure rate than free flaps in other anatomic regions. Postoperative anticoagulation and antiplatelet therapy may influence LE free flap outcomes, but an optimal regimen has not been established. This study aims to evaluate complication rates associated with different anticoagulation and antiplatelet protocols in LE free flap reconstruction.Adult patients (≥18 years of age) with LE trauma requiring free flap reconstruction at our level 1 trauma center from 2016 to 2021 were included for retrospective chart review. Complications requiring reoperation were grouped into a composite variable named major complications (i.e., hematoma, flap thrombosis, flap necrosis >10%, infection requiring reoperation). Nonrandomized patients were categorized into three groups based on postoperative anticoagulation or antiplatelet regimen (aspirin only, heparin only, and aspirin + heparin), with heparin being a subtherapeutic fixed-dose heparin infusion at 500 to 800 units/hour. Complication rates were compared across groups, and both univariate and multivariate analyses were conducted to identify associations with major complications. p-Values were set at p < 0.05.Of 191 patients, 37 (19.4%) received aspirin only, 76 (39.8%) received heparin only, and 78 (40.8%) received aspirin + heparin. Demographics were similar between the groups. On univariate analysis, the heparin group had a significantly lower rate of major complications (5.26%) compared with aspirin only (18.92%) and aspirin + heparin (20.51%; p = 0.016); however, on multivariate analysis, when accounting for additional perioperative factors, no association between anticoagulation group and major complications was found.Our study found that neither aspirin alone, heparin alone, or aspirin + heparin demonstrated a more favorable association with LE free flap outcomes. To reduce bias from the study's retrospective design and the surgeon's discretion in choosing anticoagulation protocols, future research should randomize patients to standardized postoperative regimens to assess differences in complications.

优化术后抗凝治疗方案改善下肢游离皮瓣预后。
目的:游离皮瓣重建下肢外伤的失败率高于其他解剖部位的游离皮瓣。术后抗凝和抗血小板治疗可能影响LE游离皮瓣的预后,但最佳方案尚未确定。本研究旨在评估不同抗凝和抗血小板方案在LE游离皮瓣重建中的并发症发生率。方法:纳入2016-2021年在我们的一级创伤中心接受游离皮瓣重建的LE创伤成年患者(≥18岁),进行回顾性图表回顾。需要再手术的并发症分为主要并发症(血肿、皮瓣血栓形成、皮瓣坏死bbb10 %、感染需要再手术)的复合变量。非随机患者根据术后抗凝或抗血小板方案分为三组(仅阿司匹林、仅肝素和阿司匹林+肝素),其中肝素为亚治疗性固定剂量肝素输注,500-800单位/小时。比较各组的并发症发生率,并进行单因素和多因素分析,以确定与主要并发症的关系。p值设为p < 0.05。结果:191例患者中,单服阿司匹林37例(19.4%),单服肝素76例(39.8%),阿司匹林+肝素78例(40.8%)。两组的人口统计数据相似。单因素分析显示,肝素组主要并发症发生率(5.26%)明显低于阿司匹林单用组(18.92%)和阿司匹林+肝素组(20.51%)(p = 0.016);然而,在多变量分析中,当考虑其他围手术期因素时,抗凝组与主要并发症之间没有关联。结论:我们的研究发现,无论是单独使用阿司匹林、单独使用肝素,还是阿司匹林+肝素,都没有显示出与游离LE瓣结果更有利的关联。为了减少研究回顾性设计的偏倚和外科医生在选择抗凝方案时的自由裁量权,未来的研究应将患者随机分配到标准化的术后方案中,以评估并发症的差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.50
自引率
28.60%
发文量
80
审稿时长
1 months
期刊介绍: The Journal of Reconstructive Microsurgery is a peer-reviewed, indexed journal that provides an international forum for the publication of articles focusing on reconstructive microsurgery and complex reconstructive surgery. The journal was originally established in 1984 for the microsurgical community to publish and share academic papers. The Journal of Reconstructive Microsurgery provides the latest in original research spanning basic laboratory, translational, and clinical investigations. Review papers cover current topics in complex reconstruction and microsurgery. In addition, special sections discuss new technologies, innovations, materials, and significant problem cases. The journal welcomes controversial topics, editorial comments, book reviews, and letters to the Editor, in order to complete the balanced spectrum of information available in the Journal of Reconstructive Microsurgery. All articles undergo stringent peer review by international experts in the specialty.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信